Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of GoodwillAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Varex Imaging (VREX) Asset Writedowns and Impairment (2018 - 2026)

Varex Imaging (VREX) has disclosed Asset Writedowns and Impairment for 9 consecutive years, with $1.1 million as the latest value for Q1 2026.

  • On a quarterly basis, Asset Writedowns and Impairment rose 120.0% to $1.1 million in Q1 2026 year-over-year; TTM through Jan 2026 was $4.4 million, a 2.22% decrease, with the full-year FY2025 number at $3.8 million, down 22.45% from a year prior.
  • Asset Writedowns and Impairment was $1.1 million for Q1 2026 at Varex Imaging, up from $800000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $3.7 million in Q3 2022 to a low of $500000.0 in Q1 2025.
  • A 5-year average of $1.3 million and a median of $1.2 million in 2022 define the central range for Asset Writedowns and Impairment.
  • Peak YoY movement for Asset Writedowns and Impairment: surged 400.0% in 2022, then tumbled 67.57% in 2023.
  • Varex Imaging's Asset Writedowns and Impairment stood at $2.0 million in 2022, then tumbled by 55.0% to $900000.0 in 2023, then soared by 66.67% to $1.5 million in 2024, then crashed by 46.67% to $800000.0 in 2025, then skyrocketed by 37.5% to $1.1 million in 2026.
  • Per Business Quant, the three most recent readings for VREX's Asset Writedowns and Impairment are $1.1 million (Q1 2026), $800000.0 (Q4 2025), and $1.4 million (Q3 2025).